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Chapter 1 Introduction 
 
1.1 Current opinions on Epigenetics modifications 
1.1.1 Overview of Epigenetic, its history, current theories 
 
The completion of whole Human genome sequencing is a milestone for genetics. We 
are now emerging into an era of “Epi-genetic”, where hereditable post-transcriptional 
and post-translational modifications (PTMs) are found to be crucial for all types of 
biological activities such as cancer development, regenerative engineering, and 
targeted drug development. By definition, Epigenetic is the study of heritable genetic 
traits without the change of DNA sequence. One of the many reasons we study 
epigenetic is its relationship with human cancer. According to current understanding, 
epigenetic regulates all DNA based processes including gene expression profile 
pattern, which is a critical factor for the genesis of many types of cancer. A good 
example of epigenetic cancer is found in a type of leukemia caused by an epigenetic 
regulated event of mixed-lineage leukemia (MLL) gene fusion with other genes in 
different chromosomes.  
 
In his 1957 seminal work: The strategy of the genes, Waddington first theorized the 
process of cellular development as a marble moving down a hill [1]. The marble is 
described as a pluripotent cell that moves down a hill that contains many valleys or 
different paths, as the “marble” moves down these paths, these valleys and paths give 
the cell developmental cues that make it less pluripotent and more differentiated. In 
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the end of the hill, the cell is terminally differentiated into building blocks of our 
body such as neurons, muscle cells, brain cells etc. Waddington gives us a good 
visualization of how “cell fate” influences living organisms developmentally, and 
introduced to us, for the first time the idea of epigenetic landscape which is later 
proven to be the master regulator of many biological processes, among those 
biological processes is the genesis of Cancer.  
 
Epigenetic, by definition is the heritable gene traits without change in DNA 
sequences. In a living individual, cells exist in a wide spectrum of shape, size, color; 
they have different life span, unique biological functions and mechanical properties. 
However, they all (germ line cells have half of the genetic materials) have the same 
set genomic data encoded by DNA (Deoxyribonucleic Acid); it is the modifications 
of DNA and its genetic component that makes life diversified. Some known DNA and 
Histone modifications (Fig 1.1.1) are involved in developing specific epigenetic 
landscape of a cell. It is generally understood that epigenetic landscape governs the 
patterns of gene expression during development, a specific gene is either 
transcriptional active or repressive depending on which development stage it is 
undertaking. An active gene usually located in euchromatin where chromatin is open 
for transcription factor binding and is prone to transcription expression; on the other 
hand, repressive gene is silenced in heterochromatin where chromatin structure is 
highly compact and less prone to transcription activation by transcriptional factors. 
Although there is also a transitional “melting” stage of chromatin structure, 
euchromatin and heterochromatin are the two main stages of which genetic material 
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exist. The boundaries of euchromatin and heterochromatin are demarcated by 
Epigenetic marks such as DNA methylation and Histone methylation and acetylation 
etc. DNA methylation is stable and long term repression while Histone methylation is 
more dynamic, Histone methylations are also reversible by de-methylating enzymes 
which was first discovered early this century [2].  
 
Although catalyzed by different enzyme groups, DNA methylation and Histone 
methylation pathways are speculated to be dependent on one another [3], recent 
studies have suggested that the DNA methylation is re-established in early implanting 
and this requires the help of Histone modifications [4]. Despite ample amount of 
information already published on the DNA-Histone relationship, there are still 
unknown amount of information yet to be uncovered.  
 
Methylation, in general is the covalent addition of a Methyl group to Cytosine on 
DNA or Lysine/Arginine on a Histone. The methylation reaction is catalyzed by 
methyl donor proteins coined methyltransferases, these methyltransferases all carries 
a cofactor called S-adenosyl methionine which is a bio-reactive intermediate of 
methyl group donor which transfers methyl group to the substrate. Methyltransferases 
have the ability to transfer methyl group to a variety of substrates, including DNA, 





















Fig 1.1.1 Some known posttranslational modification on Histone tails 










1.1.2 Epigenetic and Cancer 
 
During cancer progression, beside genetic cause such as DNA mutations and 
translocations, deregulation of Oncogene or tumor-suppressor gene transcription 
could also caused by epigenetic changes on their promoter region. Comparing to 
genetic mutations, a good thing about epigenetic diseases is it could be reverted by 
Epigenetic factor targeting drugs. In recent years, methyltransferases rise to be a 
promising target for drug development in several hematological cancers because of its 
selectivity and efficacy, the first four epigenetic drugs was approved by FDA in 2009 
[6], namely Vidaza, Dacogen, Zolina and Istodax. The use of epigenetic targeting 
drug helps terminal blood cancer patient to spare from painful weekly blood 
transfusions and demonstrated these kinds of drugs could give a patient some “extra 
month or even extra years”[6]. 
 
However, off-targeting effect due to lack of gene specificity is a common pitfall of 
these kinds of general epigenetic factor inhibitors. Like in Vidaza’s case, an inhibitor 
of DNA methyltransferase (DNMT), it removes overly methylated gene promoters 
that are common in high proliferating cancer cells; it could also remove inhibitory 
methyl groups from oncogenes in normal cells. This may cause wrong sets of genes 




Due to the problems with current broad spectrum epigenetic drugs, new and more 
specifically targeting epigenetic drugs are under development. Based on an online 
statistical report, the global epigenetic technology market worth $8 Billion by the 
year of 2017, these markets include a large portion in epigenetic drug development 
and cancer therapeutics. It is therefore fundamentally important to screen and 
understand the mechanisms of epigenetic factors that are potential therapeutic targets.  
 
1.1.3 Histone methylation and its effect on gene regulation 
 
Histone methylation is a type of post-translational modification (PTM), it is one of 
the epigenetic modifications under intense spotlight; currently there are over 33 
Histone sites that can be methylated, and hundreds of methyltransferases and 
demethylases doing this job [7]. Since methyltransferases are important effectors of 
gene regulation that could be translated in to drug targets having the potential to 
reduce the side effects of conventional cancer therapy, and just a fraction of these 
factors are well studied, a specific aim of this study is to identify novel Histone 
methyltransferases that may have therapeutic significance. 
 
Histone site could either be mono-, di- or tri-methylated and each kind of methylation 
has their unique biological effect. For example, Histone H3 lysine 9 could either be 
mono- or tri-methylated (H3K9me1/3), intriguingly; H3K9me1 is active gene marker 
while H3K9me3 serves as silent gene marker. Not only same Histone residue could 
have different number of methyl groups added on, but different kinds of 
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modifications (methyl-, acetyl- etc.) could also co-exists imposing impacts on gene 
circuitry network.  
Most Histone methylation are edited by mega-Dalton protein complexes harboring 
methyltransferase enzyme activities,  these protein complexes recognize the site of  
chromatin, modify it with methyl groups and induce chromatin remodeling 
machineries to organize eu/hetero-chromatin boundaries in the nucleus.  
 
 
Fig 1.1.2 The nuclear chromatin is arranged in distinct hierarchical orders, including euchromatin 
(EC) and heterochromatin (HC), and these higher structural orders are dictated by epigenetical 
regulations.  




1.1.4 Epigenetic Protein complexes 
Epigenetic modification is the main regulator of epigenetic events. It includes a wide 
variety of modifiers and among which, the most widely studied epigenetic 
modification is the addition or removal of methyl- acetyl- to DNA or Histone proteins. 
Methylation and acetylation contribute to cellular reprogramming and plasticity. Most 
of these modifications require dynamic protein complex that remodels specific locus 
on the chromatin. Examples include the SWI/SNF nucleosome remodeling complex 
and the gene silencing EZH2 complex that maintain the transcriptional repressive 
state of genes. Other types of nucleosome remodeling complex shape chromatin into 
transcriptional active state whereas the chromatin structure is open for transcription 
factors binding and active gene expression.  
 
Polycomb PRC1 complex 
A well-known epigenetic protein complex regulating gene silencing during 
development is the polycomb repressive complex (PRC). It was first discovered in 
fruit fly with improper body segmentation, later research resolved it to be a silencing 
protein complex involved in controlling the temporal and spatial expression of HOX 
gene during body development  [8]. 
 
The components of PRC1 complex are more diverse depending on the context of the 
cell being studied: PRC1 complex all contains a core E3 ligase enzyme 
Ring1A/Ring1B depositing a single ubiquitin to H2AK119, loss of Ring1B would 
result embryonic lethality cause by gastrulation arrest in mice, whereas Ring1A KO 
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mice are viable [9]. Those phenotypes suggest that one core enzyme subunit is more 
indispensable while the other may be redundant for animal development. Interestingly, 
one of the PRC1 variable subunit, the Cbx proteins are the functional bivalent switch 
of PRC1 complex function, by switching one of its subunits the Cbx homolog[10], 
PRC1 complex guide cell fate to either self-renewal or to differentiation, suggesting 
that some epigenetic complex are more dynamic in its function and in its composition.   
Polycomb PRC2 complex 
 
The PRC2 is a heterochromatin stabilizer where it deposits repressive Histone marks 
on H3k27me3 (Histon3 lysine 27 tri-methylated). Functionally, PRC2 complex is 
considered as the epigenetic memory that is required for embryonic stem cell 
maintenance. By doing CHIP-on-CHIP analysis for some of the PRC2 complex 
components, Lee et al. have demonstrated that PRC2 binding sites overlaps within a 
highly evolutional conserved vincity with the H3k27me3 marked transcriptionally 
silent genes including OCT3/NANOG and SOX2 repressed genes in human ESC [11, 
12]. Mechanistically, when the PRC2 complex was first purified, there are five 
components that forms a stable complex in HeLa cell and insect cell, but only 3 of 
these 5 components are required for its enzymatic activity in vitro, these three 
components (EZH1/2, SUZ12, EED) forms the Holoenzyme required for its 
H3K27me3 activity [13]. However other components with more transient binding 
activity also contributes to its enzyme activity, suggesting that chromatin post-
translational modification requires multi-subunit protein complex, each subunit 
performs its specific role in methyl- transferring activity to the Histone tails. One 
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enzyme alone is seldom sufficient to complete this sophisticated regulatory event; 
therefore, purifying novel epigenetic protein complex with all its Holoezymes is 
effective in understanding epigenetic regulations mechanisms and discover novel 
methyltransferase.  Our second specific aim would be trying to purify, characterize, 
and perform functional study to a new methyltransferase complex, and one of the 
major protein complex co-purified with the new methyltransferase was TREX. 
 
TREX complex 
TREX, or TRanscription and EXport complex, one of the major complexes involved 
messenger ribonucleic particles (mRNPs) complex formation and nuclear export 
through nuclear pore complexes (NPC). mRNPs formed without TREX would result 
in nuclear retention and would in some case ended up in exonuclease guided 
degradation [14, 15]. Defects in TREX would also lead to pause in transcriptional 
elongation at G/C rich gene regions and provokes genetic instability, as suggested by 
hyper-recombination phenotypes [16, 17]. 
 
Fine-tuning of the mRNP composition occurs precisely at distinct steps of RNA 
metabolism [18], and post-translation modifications such as Sumoylation has already 
been shown to be finely tuned at several steps of RNA metabolism, including 
transcription and RNA splicing [19, 20]. More interestingly, SUMO conjugation not 
only changes the micromolecular conformation of a substrate, but also often leads to 
macromolecular complexes rearrangements [21], as altered Sumoylation of TREX 
subunit Thoc1 did not affect bulk mRNA export or genetic instability but impairs the 
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expression of acid induced genes, this is a perfect example of how a distinct sub-
group of mRNP composition could be regulated by cell signals such as Sumoylation 
[22]. 
 
1.1.5 Regulation of epigenetic events by RNAs 
 
RNA is thought to be an important factor in epigenetic events more than fifty years 
ago, especially in the event X chromosome inactivation (XCI) where one of the two 
X chromosomes is silenced in female human mammalian cells by non-coding RNA: 
Xist [23]. This process occurs during early embryogenesis for the purpose of 
compensating the dosage of X-linked genes in XX females to XY males. Once 
established, this inactivation is stable and heritable throughout the next cycles of cell 
divisions, which represents a classical example of epigenetic regulation. However, 
recent findings are challenging whether Xist is the only factor attributed to XCI [24, 
25] , a key issue of whether XCI is specific to X chromosome or it reflects a general 
epigenetic mechanism to the entire genome has been raised. 
 
Five prime to Xist or FTX is another non-coding RNA 5’ to Xist gene on the X 
chromosome, it has been proposed to be a positive regulator of Xist as Chureau et al. 
have showed that deletion of the FTX promoter leads to decrease Xist expression in 
male embryonic stem cells (ES cell) [26]. However, contrary to what Chureau et al. 
had observed in ES cell lines, in Ftx-deficient female mice, Soma et al. concluded 
that Ftx is dispensable for imprinted X-chromosome inactivation during 
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preimplantation [27].  Essentially, Ftx-deficient blastocysts had normal XCI 
imprinting during preimplantation development in mice, and Ftx-deficient female 
mice are viable and fertile, which raised a hot debate on what exactly is the 
physiological role of Ftx ncRNA. 
 
Mechanistically, the molecular mechanisms of Xist and FTX are yet to be fully 
elucidated. To date, the best-studied candidates are the aforementioned polycomb 
repressive complexes. It is well established that PRC complexes are enriched on X-
chromosome inactivation sites, it is observed both in extra-embryonic [28] and 
embryonic [29, 30]  lineages. Since establishment of H3K27me3 by PRC2 is a pre-
requirement for the recruitment of PRC1 [31, 32], it is therefore considered that Xist 
RNA directly recruits PRC complexes to X-chromosome inactivation sites to induce 
another layer of epigenetic silencing like H3K27me3 [9, 33] . Biochemical data have 
also demonstrated that Xist interacts directly with PRC2 subunit Ezh2 and Suz12 in 
vitro [33-35]. Conclusively, non-coding RNAs have been a major player in chromatin 
regulation events such as chromatin silencing by facilitating Polycomb repressor 
complexes in the inactivation of X chromosome, whether they are also involved in 
chromatin activation are yet to be explored. In this study, we provided some data 
supporting that ncRNA could also be a positive regulatory factor during the activation 
of genes by epigenetical protein complexes. 
 
In conclusion, the function of these regulatory epigenetic complexes is conducted by 
cellular signal networks and signaling pathways to perform developmental or 
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biological functions, and all epigenetic changes is a result of either intrinsic or 
extrinsic signals factors, in the next chapter, we will briefly discuses some of the main 
signaling pathways and signaling molecules that is found to be the regulator of a new 
class of epigenetic factor.  
 
1.2 Signaling pathways and its relationship with Epigenetics 
 
Epigenetic enzymes is responsible for marking the transcription active or silent regions 
on the chromatin, it also respond to intrinsic and extrinsic signals and interpret 
developmental cues. Signaling factors recognize gene promoter region sequences and 
bring transcription factors including DNA and Histone Methyltransferases to mark 
transcription active region around the gene promoter, RNA Polymerase II machinery is 
thus then able to bind the opened chromatin and initiate transcription.  
 
1.2.1 STAT signaling pathways  
 
The STAT signaling pathway was originally discovered in a cytokine (IFN-g induced 
transcription activation system [36]. Since then, the STATs protein has been 
intensively studied in many systems such as immune response; stem cell pluripotency 
maintenance and cancer progression. The STATs protein is a family of transcription 
factors that had been proven to be one of most important transcription factors 
involved in animal early development and immune response. 
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The STAT signaling pathway, in its essence can be depicted as: latent cytoplasmic 
STATs protein is activated by transmembrane receptor superfamily JAK kinases, the 
phosphorylated STATs are then dimerized and translocated to the nucleus and 
activate transcription of genes at defined genome locus. Because the STAT signaling 
pathway is highly conserved across species and also due to its plethoric upstream 
receptor kinases, the STAT signaling pathway is involved in almost all major 
biological processes such as afore mentioned cancer, immune-response and cell 
development. Furthermore, recent advancement in epigenetic studies especially in 
stem cells has suggested the STAT signaling pathway has potentially a more 
intriguing mechanism in regulating the epigenetic status of a cell. It is found that 
some STATs promote active epigenetic marks; while some STATs promote 
antagonize epigenetic marks [37]. Enhanced STAT 3 activation promotes the re-
programming of terminally differentiated cell, either by introducing de novo 
methylation of DNA through up regulating DNMTs or by suppressing the expression 
of major chromatin repressors [38]. There is still lack of evidence proofing STAT 
transcription factors could directly influence epigenetic re-programming. 
 
STAT is latent until being activated by cell surface signal receptors and 
phosphorylated by cytosolic kinases such as JAK and FAK,   STAT is then 
transactivated into nucleus and initiates gene transcription at specific locus. Among 
those genes being transcribed by STAT we have recently discovered a new family of 
gene that encodes a functional unknown protein called the Methyltransferase Like 
(METTL8) protein.  This novel protein family has the potential to be a new regulator 
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of important epigenetic events such as reprogramming, bookmarking, imprinting or 
gene silencing. 
 
1.2.2 Transcription factors and cell reprogramming 
 
It is demonstrated that many transcription factors especially the well-known 
Yamanaka factors: Oct4, Sox2, Klf4 and cMyc, have the power to reprogram 
differentiated human fibroblast cells back into pluripotent stage. In which terminally 
differentiated cells re-gain their ability to differentiate into other cell lineages and 
maintained a “stem-cell” like status if cultured under medium containing certain 
cytokine [39, 40]. Further studies have revealed that the transcription factors that 
Yamanaka et al. introduced into human fibroblast cells somehow have the ability to 
reshape Histone methylation landscapes by bringing specific methyltransferases to 
defined locus where chromatin can either be released from Histone packaging and 
ready for transcription or compacted into heterochromatin and remain silent 
trancriptionally [41]. The transcription-ready state is coined by some peoples as the 
“melting state” [42] in which the transcription active regions of a genome is 
organized into inter- or intra- chromosome hubs, these mRNA producing hubs are 
organized into high-level 3D structures where many transcription factors bind DNA 
elements far from its linear DNA elements, suggesting that one active chromosome 




Above advancements in both stem cell biology and genome research have suggested 
one intriguing question: How could transcription factors impact the entire 
transcriptional landscape of a genome? Although many models have been proposed 
explaining this question, how is the exquisite gene network respond to the even more 
complex networks of cellular signals remained unanswered.  
 
Working in a lab in which STAT was originally discovered, I am fortunate to work on 
such problem. As once coined by my main supervisor, Peri-genetic (around-gene) 
could be a generalizing term summarizing this hypothesis and also a theory that 
guides me through the study of epigenetics. And a best example of peri-genetic 
regulation discovered by me is another layer of genetic regulation such as 
Sumoylation. 
 
1.2.3 Sumoylation signaling pathways 
 
Sumoylation (SUMO) signaling pathway posttranslational modifies target proteins 
with a family of ~10kDa size proteins nomenclature as SUMO-1, SUMO-2, SUMO-3 
and SUMO-4 in mammals. These small proteins are covalently attached to target 
proteins by a series of enzymatic steps catalyzed by SUMO-conjugating enzymes E1, 
E2 and E3. Unlike its evolutionary close brother Ubiquitin, these covalent modifiers 
does not direct target proteins to degradation but rather functions at a plethora of 
biological actives including: change substrate binding partners, alter substrate cell 
compartment localization, affects the activity of an enzyme, and if the substrate is a 
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transcription factor, Sumoylation usually repress its transcriptional activity. 
Collectively, SUMO has been showed to be mainly involved in the aspects of 
chromatin dynamics regulation in the nucleus. However, among its ~60 SUMO target 
proteins reported so far, significant amount of them are either transcription factors or 
DNA transaction related proteins, little is known about the role of Sumoylation in 
epigenetic.  
 
Sumoylation is much simpler than Ubiquitination in the aspect of enzymes 
participated in the reaction, mainly because there is one E2 (UBC9) responsible for 
transferring the activate SUMOgg from the SUMO activating complex (AOS1/UBA2) 
to the substrate, therefore a conserved modification motif ΨKXE (where Ψ is a 
hydrophobic residue, K is the lysine conjugated to SUMO, x is any amino acid (aa), 
D or E is an acidic residue) could be deducted based on the specificity of the E2 
ligase UBC9. In this study, I report Sumoylation is responsible for regulating 
epigenetic events by modifying a member of a novel super-family of 
methyltransferase at an evolutionary conserved amino acid residue. This finding 
offers foundation for further study elucidating that posttranslational modification such 
as Sumoylation could influence chromatin state by altering the activity of an 
epigenetic factor. 
 
METTL8 is a member of Methyltransferase Like family also known as Tension 
induced proteins (TIPs), it harbors several conserved functional domain including an 
s-adenosyl-L methionine binding motif, a common co-factor involving methyl group 
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transferring1, 4. TIPs are originally found to belong to a group of genes induced by 
mechanical stretch or tension in lung embryonic mesenchymal cells. Preliminary data 
have indicated that METTL8 is functional in maintaining pluoripotency and 
responsive to gamma-irradiation induced skin cancer. Above cellular functions all 
require the opening and closing dynamics between hetero- and eu- chromatin, and 
this dynamic is likely to be regulated by epigenetic modifications such as methylation. 
METTL8 is therefore highly susceptible to be a novel functional methyltransferase 
with new substrate specificity. Additionally, METTL8, being a potential 
methyltransferse itself, its true substrate still remains elusive. It has only been shown 
that METTL8 facilitates the acetyl- transferring activity of P300 on active 
transcription promoters, this is not be the direct substrate since METTL8 only has the 
potential to transfer Methyl groups but not Acetyl groups. Moreover, although it has 
been showed that METTL8 facilitates Acetylation, Acetyl and Methyl modification is 
not mutually exclusive on the same Histone, they can be either synergetic or 
antagonistic to gene expression at the region of modification depending on the 










Chapter 2  Methods and Materials 
 
2.1 Cell culture and generation of inducible protein complex system 
 
HeLa S cell line is maintained at 37℃, 5% CO2 until 80% confluence before each passage, 
HeLa S suspension culture is achieved by inoculating exponential growth HeLa S cell 
into 10 liters of JMEM (Product No.: M0518 SIGMA) containing 10% FBS and 1% Pen-
strep in a Corning Proculture spinner flask (Product No.: CLS4500125 SIGMA). 
Inducible EF1a-FLAG-hMETTL8-HA stable cell line is generated by tranfecting 
Clonetech (Cat. No.: 631337) TET-ON 3G vectors containing the EF1a-FLAG-
METTL8-HA cassette with Blasticidine selection marker into HeLa S cell line, then the 
transfected HeLa S cells were maintained under 100 uM Blasticidine selection medium 
for two weeks or until colonies appeared. Positive colonies were handpicked and 
subjected to inducible expression profiling, final Doxocyclin (Product No.: 
D3447 SIGMA) concentration for optimal level of METTL8 protein expression is 
deciphered at 0.125 ug/ml. 
 
2.2 Large scale nuclear extracts preparation 
 
Extraction of the S100 
High density cells were removed from the incubator (turn off CO2), cells were counted 
and density was calculated. Cell is then spined for 15 min at 2 K rpm in a tissue culture 
centrifuge at 4℃ centigrade. The cell pellets were re-suspended in PBS and spined at 2K 
rpm for 15 min, PCV (packed cell volume) is then recorded. The cell pellet is rinsed with 
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HB and re-suspended by gentle shaking and spined at 2.5 K rpm for 5min. ¼ x PCV of 
HB were added to each tubes and carefully resuspend the pellet, then it is homogenize 8-
15 times in a 40 ml homogenizer with a “B” pestle.  Percentage of the lysis is checked 
microscopically after 6-8 strokes. Lysate were spun at 3.9 K rpm for 15min and the 
individual NPV (nuclei pellet volume) was recorded, aspirate the s100 supernatant and 
freeze it in -80℃ degree. 
    
Extraction of the nuclei  
The nuclei pellet were re-suspend in ½ volume of the Low Salt Buffer, homogenize 6 
times and pour into a beaker with stir bar. Next, add high salt buffer drop wise to the 
homogenized nuclei while still stirring, incubate nuclei in high salt buffer at 4℃ for 1 h. 
Next, spin the nuclei high salt solution at 14 K for 30 m (4℃), and pour supernatant into 
prepared dialysis tubing and begin dialysis in previous prepared dialysis solution (BC-
100). Continue dialysis of extract until conductivity reaches that of BC100 (50-60 µS). 
Spin nuclear extract at 36 K for 20 m and record time of completed spin. Pour 
supernatant into 50 ml capped tubes and one 1.5 ml aliquot tube each labeled “Hela 
Nuclear Extract plus Date”.  
 
2.3 Liquid chromatography and purification scheme 
 
Packing and equilibrating of Whatman P11 column 
P11 Phospho-cellulose resin powder is purchased from Whatman (Cat. No.:4071-010) 
and swelled in ddH20 overnight, the resin slurry is then poured into xk 16/20 column GE, 
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the resin bed is packed with a packing reservoir at a flow rate of 0.5 ml/min. After 
packing, the column is equilibrated with 2 times column volume of binding buffer before 
loading cell nuclear extract 10ml of 10 mg/ml nuclear extract was loaded onto the P11 
column in low ion strength buffer (10 mM Tris-Hcl, 50 mM NaCl, pH 8.0) and the 
bounded proteins were step-wise eluted with buffer containing 100 mM, 300 mM, 500 
mM and 1 M of NaCl (Fig. 2.1). Each step-fraction was pooled and subjected to western 
blot analysis using antibody specified in result section. The peak contain the highest 
amount of target protein was dialyzed with low ionic buffer overnight at 4℃  and 
subjected to the next step of purification. 
 
Fig. 2.1 Elution conditions for P11 cation exchange bound nuclear extract 
 
Generation of antibody coupled NHS-agarose affinity column  
NHS-agarose-antibody column is generated according to manufacturer’s 
recommendation, briefly: 1ml of NHS column is washed with 2 CV of ice cold 1 mM 
HCL, immediately followed by application of ~10 uM of antibody in coupling buffer and 
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the column was sealed and incubated at room temperature for 1 hour. After incubation, 
NHS column is deactivated with 3 column volume of high pH buffer (0.5 M 
ethanolamine + 0.5 M NaCl, pH 8.3) followed by 3 column volume of low pH buffer (0.1 
M acetate + 0.5 M NaCl, pH 4). Repeat the high pH and low pH washing cycle for two 





















Affinity purification with custom generated NHS antibody column 
Dialyzed P11 fractions from previous steps were centrifuged to remove traces of 
precipitation before loading onto the antibody column using a peristaltic pump. To ensure 
maximum antibody-antigen binding capacity, the sample was repeatedly passed through 
the antibody column at a flow rate of 0.2 ml/min for up to 16 h at 4℃ in a cold room. 
After applying the sample with the peristaltic pump, the charged column is linked to a 
FPLC system for wash and elution steps of the immune-captured protein complex. The 
wash steps include 2 CV of binding buffer (10 mM Tris-Hcl, 50 mM NaCl, pH 8.0) 
equilibration and 2 CV of low ionic strength buffer (10 mM Tris-Hcl, 100 mM NaCl, pH 
8.0), after the wash, the complex is eluted with buffer containing 500 mM of NaCl. 
 
Gel filtration using Superose 12 column 
Gel filtration column was used to characterize the native size of the immune-purified 
protein complex; the sample is loaded and eluted with 1.5 CV isotonic buffer (10 mM 
Tris-Hcl, 150 mM NaCl, pH 8.0). 
 
Mono S strong cation exchange column 
Mono S strong cation exchange column was chosen for the final polishing step because it 
has good resolution due to its strong negatively charge resin and fine particle size. The 
column is first equilibrated in binding buffer (10 mM Na-phosphate, 10 mM NaCl, pH 
6.0), and sample dialyzed in the same buffer was loaded on to the column with 
ÄkTAFPLC (Product code: 18-1900-26) system. The complex was eluted in a stepwise 
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method, a salt gradient of 30 mM, 100 mM, 300 mM and 500 mM were pumped into the 
column and the complex was collected at 500 mM. 
 
2.4 Expression and purification of recombinant proteins 
 
To obtain purified, active proteins for in vitro enzyme assays, GST-UBA2, GST-AOS1, 
6*HIS-UBC9, 6*HIS-SUMO1, 6*HIS-METTL8, 6*HIS-METTL8-K80R and 6*HIS-
SUMO1gg were expressed in BL21 E. coli. at 20℃ under 100 µM IPTG induction for a 
period of 10~16 hours. Cells were then harvested by centrifugation and resuspended in 
cold PBS and sonicated twice at 10 Watts 5 m to dissolve the recombinant proteins. The 
proteins were pre-cleared by centrifugation and passing through empty agarose column 
which helps removing background binding contaminants. Lastly, the pre-cleared protein 
lysates were loaded either onto Gstrap (Code: 17-5281-01, GE healthcare) or Histrap 
(Code: 17-5247-01, GE healthcare) columns and the bounded recombinant proteins were 
eluted with 10 mM glutathione and 0.2 M imidazole respectively.  
 
The purified proteins were dialyzed against 10 mM Tris-Hcl (pH 7.9) + 3 mM MgCl2 to 
remove Imidazole and Glutathione. Protein concentration is determined by UV 
absorbance and snap frozen in liquid nitrogen for storage up to 3 month in -80℃. 
 




To construct enzymes for in vitro and in vivo assays, gene cloning using cDNA library 
generated by reverse transcription was performed to obtain the coding DNA for the 
following genes: UBC9, SUMO1, METTL8 (human) and AOS1. The first strand cDNA 
library of total mRNA is amplified by Superscript III reverse transcriptase (Invitrogene), 
poly-deoxy-thymine nucleotides was used to prime the mRNA specific reverse 
transcription reaction. Then, the newly synthesized cDNA was used as the template for a 








Duet1sumo1not1:   ggcggccgcAACTGTTGAATGACCC 
 
Amplified gene fragments were then digested with the designated restriction enzymes 
and linked onto PET-Duet1 vectors (Novagene) treated with the same pair of restriction 
enzymes. 
 




All western blot was done according to BioRad Mini-PROTEAN and Mini Trans-Blot 
electrophoretic Transfer Cell protocol. Silver staining was also done with BioRad Silver 
Stain Plus kit. 
 
2.7 In vitro methylation and sumoylation assay  
 
In vitro sumoylation is carried out with a master mix of 2 ug GST-UBA2, 1 ug GST-
AOS1 and 0.5 ug 6*HIS-UBC9, in combination with 3 ug of 6*HIS-SUMO1 and 1~10 
ug of METTL8 or its K80R mutant. These enzymes are then incubated in buffer 
containing a final concentration of 10 mM ATP at 37℃ for 1 hour. The reaction is 
stopped by adding ½ volume of 4X SDS-PAGE sample buffer and boiled for WB or 
further analysis. 
In vitro methylation is carried out with a master mix of 2 ul S-adenosyl-L-[methyl-3H]-
methionine, 2 ug of METTL8 or Sumo-METTL8 protein, in combination with either 1ug 
of core Histone from chicken erythrocytes or 1 ug polynucleosome from HeLa nuclei. 
These components are incubated in Histone methyltransferase buffer (25 mM Tris-Cl at 
pH 8.0, 20% glycerol) at 37℃ for 1 hour, and the reaction is stopped by adding ½ 
volume of 4X Laemili buffer and boiled for SDS-PAGE separation. The gel was stained 
with Coomassie Blue for 1 h and destained until the substrate bands of interest are visible. 
After destaining, the gel is photographed or scanned for documentation. Next, the gel is 
placed into a clean tray and ~10 mL of ENLIGHTNING (Product no.: 6NE9741, 
KODAK) solution was added for 30min incubation at room temperature with gently 
shaking. To dry the gel for autoradiography, the gel was placed on top of a Whatman 
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paper and placed in a gel dryer for 1 h at 80°C. After the gel was dried, insert the gel and 
a piece of X-ray film in an autoradiography cassette and place it at −80°C for 1-2 weeks. 
 
2.8 RNA extraction, reverse transcription and Q-PCR 
 
Total RNA is extracted using Trizol method. Mammalian cell line growing at ~90% 
confluence in a 10cm dish is lysis with 1ml of Trizol (Product no.: 15596018, Life 
Technologies) reagent on ice, the cell is then scraped with a plastic scraper and 
transferred into a tube, 200ul of chloroform is then added and the Lysate and the mixture 
is incubated at room temperature for 5 min to disassociate the cellular protein-nucleic 
complexes. Next, the water soluble and organic phase are separated by centrifugation at 
10,000 g, the RNAs remain exclusively in the water soluble phase. The RNA is pelleted 
with 2.5 ml of isopropanol at a centrifugation force of 10,000 g. Lastly, the RNA pellet is 
washed twice with 75% of isopropanol and dissolved in ~50 ul of water. 
 
Reverse transcription is carried out according to manufacturer’s instruction (Invitrogen 
SuperScript III) with minor modification. Purified RNA were either reverse transcribed 
with Poly-dT primer or random Hexmer primer using SuperScript III Reverse 
Transcriptase, the reaction is incubated at 50 ℃  for 30 min and the reactions is 
terminated at 85°C for 5 min before RNAse H is added to remove RNA templates. The 







In collaboration with Dr. Manfred Raida, a Fasp (filter-aided sample preparation, Product 
no.: 44250, Expedeon) [44] aided mass-spectrometry was incorporated downstream of 
the complex purification.  Peptides from the protein complex were extracted and 
solubilized and loaded onto Fasp columns, samples were then alkylated, washed and 
digested on filter column. Digested peptides were then eluted, and dissolved in 0.1% 
formic acid in water. The digested peptides are then loaded onto an LC-MS machine to 
analyze the species but our collaborator. The eluted peptides were next submitted to 
nano-flow HPLC coupled to a QTOF mass spectrometer (1260 nanoHPLC [Agilent 
Technologies] and QTOF 6554 with ChipCube [Agilent Technologies]). Separation of 
peptides were done on Chip II (C18 Reprosil column), the gradient applied to the chip 
was from 8% to 35% acetonitrile. Raw data were converted to mzdata.xml using 
MassHunter (Agilent Technologies) and loaded onto PEAKS software and database 
search was performed against human IPI database (version 3.65), Carboxymethylated 
Cys was set as fixed modification, oxidized Met, deamidation of Asn and Gln, pyroGlu 
formation of the N terminus and acetylation of the N terminus as variable modification.  
 
2.10 Par-clip and RNA immunopreciptiation 
 
In collaboration with Dr. He Chuan of Chicago University we utilized photoactivated-
ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) as a 
discovery tool for METTL8 binding RNAs. We incorporated photoreactive ribonuleoside 
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analogs into nascent RNA transcripts in living cells, and irradiated the cells with UV at 
365nm inducing efficient crosslinking of the photoreactive nucleoside-labeled RNAs to 
interacted with RBPs, then the FLAG tagged METTL8 protein complex is 
immunoprecipitated from the photo-activated cells and the crosslinked and 
coimmunoprecipitated RNAs were isolated. The isolated RNAs were then reverse-
transcribed into cDNA library and subjected to deep sequence using next-generation 
sequencing technology. 
 
2.11 Glycerol gradient centrifugation 
The glycerol gradient was created either using an FPLC program, or by making 5~6 
different glycerol solutions and layer those in a 5mL ultracentrifuge tube Centrifuge Tube. 
The SW55ti rotor was used and the speed was set to 45,000 rpm ~200,000xg. The 
samples were loaded on top of the gradients slowly and evenly (100uL of sample). After 
applying the sample, carefully load the gradient into the centrifuge and make sure that the 
rotor is balanced correctly, run for 16-18 hours overnight at 4°C. 
 
2.12 CRISPR/Cas9 directed knock out 
CRISPR-Cas9 mediated knockout cells was done following the instruction of ZiFit to 
design targeting guiding RNA on human Mettl8 coding region [44]. 
 
2.13 Native gel electrophoresis 
Native gel electrophoresis was performed using the same system as Bio-rad SDS-PAGE 




Chapter 3: Scopes and specific aims 
 
A scope of the study will be surrounding a screen for novel epigenetical factors, 
identified their interacting partners to understand or their function and evaluate the 
physiological significance. However, screening for drug targets of these novel 
epigenetical factors will not be covered in this study. 
 
Aim 1: 
Since Stat3 is a critical transcription factor downstream of the LIF signaling pathway 
in maintaining ES cell pluoripotency, and clearly epigenetic mechanisms are involved 
in this process, we anticipate Stat3 functions upstream of unknown epigenetic 
modifiers. Therefore, the First specific aim of this study is to screen for novel 
epigenetic factors (enzymes) that may have physiological or therapeutic significance. 
 
Aim 2: 
Next step after screening is to characterize the function of the novel epigenetic factor. 
Since most epigenetic enzymes exist in macro-molecular protein complex, and 
identifying known interacting protein partners would facilitate the discovery of 
enzyme function. Our second specific aim would be to purify and characterize the 
components of the purified protein complex using liquid chromatography coupled 





After successfully completing Aim 1 & 2, together with epigenetic complex 
components identified, we would analyze the binding partners with known functions, 
and predict possible molecular functions of our target epigenetic factor. Our third 
specific aim would be to test the predicted functions using different assays and animal 
model; furthermore, we would also test all the common suspects for the substrate of 




















Chapter 4: Results 
Part 1 Purification and characterization of a novel epigenetic complex from HeLa 
nuclear extract 
 
Result Part 4.1  
A novel potential epigenetical factor is discovered using STAT3 knock out and wild 
type cell line, this epigenetic factor exists in a mega-dalton protein complex in the 
nucleus. 
Fig 4.1.1 A novel epigenetic factor is characterized as STAT3 signaling regulated 
enzyme bearing potential Methyl transferring activity.  
 
Earlier research reports have suggested transcription factors could reprogram a cell’s fate 
by reconstructing its epigenetic landscape, to delineate the relationship of transcription 
factors and epigenetic regulation at molecular level, our lab took advantage of a STAT3 
knock-out Hct116 cell line and a library of primers targeting known or potential 
epigenetical factors. After re-introducing STAT3 into the knock-out cell line using virus 
infection, both the knock-out cells and the virus re-introduced cells were subjected to 
total RNA extraction and quantitative PCR analysis. Several candidate genes where 
observed by our lab to be up-regulated in the STAT3 positive cells after cytokine 
Oncostatin M (OSM) treatment, these candidates includes NDST3, IRF8, HOXB9 and 
METTL8. Among those STAT3 dependent, OSM up-regulated genes, METTL8 appears 
to be a potentially attractive novel epigenetic enzyme because it possess an evolutionary 
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conserved methyl-donor (s-adenosylmethionine SAM) binding motif, which could 
catalyze the transferring of the  –CH3 group from SAM to a substrate. Furthermore, 
METTL8 appears to be a epigenetic factor influencing cell fate at global transcription 
level since it has been reported to be a tension induced protein [45], how METTL8 















Fig 4.1.1 Identification of a novel STAT3 regulated potential epigenetic factor METTL8 
A. Western blot showing STAT3 knock out Hct116 cells and STAT3 knock out re-
introduced cells treated with mOSM (10 ng/ml) at various time points, protein were 
isolated and visualized with anti-STAT3, anti-STAT3 (pY705) and α-Tubulin antibody. 
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B. Quantitative PCR screening for epigenetic genes in STAT3 knock out Hct116 cells and 
STAT3 knock out Hct116 cells re-introduced with recombinant STAT3. Cells were either 
mock treated or treated with mOSM (10 ng/ml) for 1 hour. 
 
Fig 4.1.2 METTL8 protein forms a complex at the size of 700kDa in HeLa nuclear 
compartment. 
 
The METTL8 gene encodes a protein at molecular size of ~45 kDa, and it is translated 
both in the cytosolic and nuclear compartment of a cell. Since there are no biochemical 
studies done on METTL8 protein before, the first question we asked is whether there is a 
difference between the cytosolic and nuclear METTL8 protein. Apparently, both from 
linear and segmented gradient glycerol sedimentation assay, the nuclear METTL8 protein 
form a much larger macro-molecular molecule than the cytoplasmic counterpart. Using a 
size exclusion chromatograph technique, the native nuclear METTL8 complex size is 
estimated to be around 700 kDa, 15 times larger than the protein itself. Intriguingly, not 
only the nuclear METTL8 forms a larger protein complex than cytoplasm counterpart, 
the protein itself also seems to be modified in the nucleus but not in the cytoplasm. Hence, 
we decide to purify the nuclear METTL8 protein complex and find out what the essential 





































Fig 4.1.2 METTL8 protein forms a complex at the size of 700kDa in HeLa nuclear compartment. 
 
A. Glycerol gradient centrifugation of wild type HeLa nuclear extract and cytoplasm extract, 
extracts were layered on top of a cushion of increasing segment gradients of glycerol in 
10 mM Tris-Hcl (pH 7.9) before ultra-centrifuged overnight, protein were fraction eluted 
and visualized with anti-METTL8 antibody. 
B. Glycerol gradient centrifugation of wild type HeLa nuclear extract and cytoplasm extract, 
extracts were layered on top of a cushion of increasing linear gradients of glycerol in 
48 
 
10mM Tris-Hcl (pH 7.9) before ultra-centrifuged overnight, protein were fractioned and 
visualized with anti-METTL8 antibody. 
 

















C. Size exclusion chromatography of wild type HeLa nuclear extract and cytoplasm extract, 
sephacryl 300 16/60 mm column were used at a flow rate of 1ml/min, equal volumes of 
nuclear extract and cytoplasm extract were loaded and equal volumes of fractions were 
collected both for nuclear extract and cytoplasm extract. Alternative fractions were taken 
and protein was visualized with anti-METTL8 antibody. 
D. Size exclusion chromatography of HeLa nuclear extract stably expressing FLAG-
METTL8 together with gel filtration markers, HeLa nuclear extract were loaded onto 
sepharose 12 column together with 1 mDa and 669 kDa markers, equal volume fractions 
were collected and visualized with both anti-FLAG and anti-METTL8 antibody. 
E. Size exclusion chromatography of purified METTL8 complex, immunoprecipitated 
METTL8 complex was loaded on to a sepharose 12 column and the absorbance of UV at 















Fig 4.1.3 Large scale purification of HeLa nuclear METTL8 protein complex and 
complex subcomponent identification using FASP-LC-MS. 
 
The purification scheme starts with 10 liters of suspension cultured Hela S3 stable 
expressing FLAG and HA fused with human METTL8 coding DNA. Total around 100 
mg of nuclear protein was loaded onto Whatman P11 Cation exchange column to capture 
the crude DNA-binding protein complexes, the METTL8 complex was eluted at a salt 
concentration of 200 mM NaCl. Next, the 200 mM NaCl nuclear fractions was dialyzed 
against low salt binding buffer and loaded onto tandem HA-FLAG affinity column, the 
immune-complex was eluted with high salt washing buffer with ionic strength of 1 M 
NaCl. Again, fractions from the immune-complex were pooled and dialyzed against low 
salt binding buffer. To polish the protein complex and remove impurity, the dialyzed 
immune-complex was loaded onto Mono S strong cation exchange column and eluted at 
an ionic strength of 0.5 M of NaCl (Fig 4.3A), binding fractions of Mono S column were 
further polished with Mono Q strong anion exchange column. The amount of the final 
purified METTL8 protein complex is around 8 ug, the purification fold is estimated to be 
12,500 times. 
 
The components of the METTL8 complex was visualized on gel, native purified 
METTL8 complex was boiled in SDS sample buffer and loaded onto 15% and 5-15% 
SDS-PAGE gel, after electrophoresis the protein bands was visualized by silver staining 
(Fig 4.3 B). Majority of protein bands locate near the 75kDa-25kDa range while there are 
also some bands located at higher molecular weight above 200kDa. To verify previous 
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results (Fig 4.2) showing that the native molecular size is around 700 kDa, a different 
approach was tested: purified METTL8 complex was electrophoresis on a native 8% 
Acrylamide gel together with 2 MDa, 669 kDa and 200 kDa molecular weight marker, 
after probing with anti-METTL8 antibody, the native molecular weight of the complex 
was indicated to be around 700 kDa, very close to gel filtration and glycerol 
sedimentation data shown previously (Fig 4.1.2). Taken together, the purified nuclear 
METTL8 complex consists of approximately 20 unique subunits co-binding together and 
formed a 700 kDa protein complex in the nucleus of a cell. Logically, the next step is to 
identify each component of the complex, our first strategy to achieve this goal was by 
mass-spectrometry. 
 
Total of 32 unique proteins were identified through filter-aided-sample-prep mass-
spectrometry (FASP-LC-MS), surprisingly 14 of them can be group into 5 known protein 
complexes (Table 4.1) with defined molecular functions including: DNA damage repair, 
RNA splicing machinery, T-cell specific transcription factor complex and RNA 
transcription and export protein complex. This protein complex elucidated the many 
facets of METTL8 functionality, also consolidated previous finding that METTL8 is 
localized in speckles (were RNA splicing take place) during early stage embryonic 
development, and additionally, METTL8 was also found to inhibit DNA damaging 
response by suppressing ATM activation. Whether the RNA spliceosome complex 
METTL8- SFPQ-NONO-MATR3 and the DNA damage response complex METTL8-
KU70/80-PRKDC are the reason of, or in some way link to above mentioned findings 
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Fig 4.1.3 Large scale purification of HeLa nuclear METTL8 protein complex and complex 
subcomponent identification using FASP-LC-MS 
 
A. A schematic representation of the large scale METTL8 complex purification steps. 
B. Silver staining of the purified METTL8 complex, a 12% uniform acrylamide gel was 
used to separate protein components of the METTL8 complex, NHS conjugated with 
Rabbit IgG was also used as negative control. The proteins were visualized directly with 
silver staining.  
C. Native polyacrylamide gel electrophoresis of the METTL8 complex. Purified METTL8 
complex was electrophoresis separated on 8% native gel before transferred onto a 
nitrocellolus, and native size of METTL8 complex was visualized by western blotting 
using indicated antibody. 





























































E. SDS-PAGE silver staining of the nuclear METTL8 complex annotated with components 

















Acetyltransferase NAT10 acetylate both Histones and microtubules. 
Histone acetylation may regulate 




USP39  Plays a role in pre-mRNA splicing as a 
component of the U4/U6-U5 tri-snRNP, 
one of the building blocks of the 
spliceosome. Regulates AURKB mRNA 
levels, and thereby plays a role in 
cytokinesis and in the spindle checkpoint. 
Does not have ubiquitin-specific peptidase 
activity, but could be a competitor of 









1.Nuclear retention of defective RNAs 
2.SFPQ-NONO heteromer may be involved in 
DNA nonhomologous end joining (NHEJ) 
NFAT complex ILF2-ILF3 1. a transcription factor required for T-cell 
expression of the interleukin 2 gene.  
2.binds RNA and is an essential component 
for encapsidation and protein priming of 
hepatitis B viral polymerase.  
3. The complex has been shown to repair 
DNA breaks by NHEJ and also negatively 





The XRCC5/6 dimer acts as regulatory 
subunit of the DNA-dependent protein kinase 
complex DNA-PK by increasing the affinity of 
the catalytic subunit PRKDC to DNA by 100-
fold. The XRCC5/6 dimer is probably involved 
in stabilizing broken DNA ends and bringing 
them together.  
Subset of SWAP 
complex 
NPM1-NCL-PARP1 x-linked hyper igm syndrome, and nodular 
lymphocyte predominant hodgkin 
lymphoma. 
Subset of TREX 
complex 
THOC1-THOC2 releasing mRNA from nuclear speckle 
domains.  
Required for efficient export of 
polyadenylated RNA and spliced mRNA. 
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Fig 4.1.4 Physiological functions of METTL8 and TREX complex is relevant: Both adult 
METTL8 and Thoc1 (TREX subunit) knockout male mice are infertile; this is due to 
similar testis developmental defects in the formation of tubules.  
 
We have collaborated with Dr. XU Juan from Nanjing model animal center and 
successfully generated the total Mettl8 knockout mice. To our surprise, the knockout 
phenotype of Mettl8 in mice testis is striking similar to that of Thoc1 hypomorphic 
knockout mice (Thoc1 total knockout is embryonic lethal). With reduced testicular 
tubules formation and infertile male littermates (Fig 4.1.4 A), the knockout phenotype 
suggests Mettl8 protein is important for genome stability and RNA biogenesis which is 
critical during spermatogenesis. The similarity of phenotype also indicates that there is 
overlapping function with Mettl8 and Thoc1 at least in mice, and it is very likely that 
Mettl8 is an important co-factor that influences the ability of the TREX complex in 
coupling RNA transcription and RNA export; thus maintaining the stability of the 
genome by regulating the formation of DNA-damaging inducing DNA:RNA hybrid 
structure: R-loop [46]. 
 
Although Mettl8 knockout mice is not embryonic lethal, unpublished data from our lab 
have shown that knockdown of Mettl8 resulted in loss of ES pluoripotency and re-
expression of developmental genes (Vinh Do D. et al.). Suggest that Mettl8 plays an 




Next, we validated our prediction using CRISPR/Cas9 directed knockout in human 
cancer cell lines. A general pattern was elucidated: total knock out of METTL8 in human 
colon cancer cell line HCT116 showed dramatic decrease of RNA: DNA structure in the 
nucleus comparing to wildtype HCT116 cells. In an immunofluorescence assay, by using 
RNA-DNA (R-loops) specific antibody (Product no.: ENH001, Kerafast), we have 
showed that METTL8 knock would result almost a total disappearance of R-loops 
structure in the nucleus of human colon cancer cell line and HeLa cell line (Fig 4.1.4 C). 
In a Dot blot assay, the same loss of R-loops pattern was also observed in the purified 
nucleolus of human colon cancer cell line and HeLa cell line (Fig 4.1.4 D). Suggesting 
METTL8 may have an opposite function comparing to its binding partner THOC1/2 
which protects the genome from the formation of R-loops during transcription. The exact 
mechanism of METTL8 induced R-loop formation awaits further investigation, however, 
given that METTL8 is a potential Methyltransferase, we could foresee the possibility that 
METTL8 could influence the RNA: DNA structure with its enzyme activity. 
 
Additionally, immune-staining of Thoc1 subunit of TREX complex also revealed Thoc1 
co-localize with METTL8. Thoc1 showed a more dispersed nuclear localization while 
METTL8 specifically localized to the euchromatin areas in the nucleus (Fig 4.1.4 B), 
suggesting METTL8 could be an euchromatin inducing factor while Thoc1 took part both 
in heterochromatin and euchromatin organization. Their relationship is likely to be 
conventional TREX complex is a more generic regulator of chromatin structure but 
METTL8 binding Thoc1 complex function as specific gene-activator in the actively 
transcribing gene regions. 
58 
 
Fig 4.1.4 METTL8 knockout male mice are infertile due to similar testis developmental 
defects in the formation of tubules in Thoc1 dysfunctional mice. Thoc1 protein co-
localizes with METTL8 in HeLa cell lines and METTL8 promotes the formation of R-
































A. Hematoxylin and eosin staining of METTL8 knockout mice testis seminiferous tubules, 
sagittal and coronal sections of METTL8 knock mice testis is stained with H&E, asterix 





B. Immune-staining of endogenous Thoc1 and METTL8 protein. HeLa cells were fixed with 
3% paraformaldehyde and permeabilized with 0.2% Triton-X and stained with anti-
Thoc1 (mice) and anti-METTL8 (rabbit) primary antibodies and goat-anti-mice-DsRed, 
goat-anti-rabbit-FITC secondary antibodies. The fluorescence is captured under oil lens 




































C. METTL8 promotes R-loops formation in vivo. WT and METTL8 Crispr KO Hct116 cells 
were fixed with 3% paraformaldehyde and permeabilized with 0.2% Triton-X. WT cells were 
either treated with RNAse A or RNAse H. They are then stained with anti-DNA: RNA hybrid 
antibody (Antibody Online) overnight at 4℃ and goat-anti-mice-DsRed (Alexa Fluor) 
secondary antibody. Nuclear DNA was stained with DAPI (blue). The fluorescence is 
captured under oil lens of Nikon AIR1 laser confocal microscope. 
D. Dotblot display of R-loop structures from nucleolar extract. Equal quantity of nucleic acid 
from the nucleoli of either wildtype or METTL8 knockout HCT 116 cells, or HeLa cells are 
purified and dot-loaded onto nylon membrane. The amount of R-loops was visualized with R-

















Conclusions for Result Part 4.1 
 
In this part of the study, I purified the nuclear complex of a new potential 
methyltransferase (METTL8) that was identified to be a novel transcriptional target of 
STAT3. This complex was measured to be around 700kDa in size and is composed of 
protein subunits from the RNA splicing complex, the NFAT complex, the DNAPK 
complex, subsets of SWAP complex and subsets of the TREX complex. Collectively, 
based on the reported functions of the METTL8 interacting proteins, METTL8 is mostly 
likely to be involved in active transcription sites where nascent RNAs are being 
transcribed, spliced, processed and exported via the nuclear pore basket complex, 
specifically by promoting the formation of RNA: DNA hybrid during transcription of 
RNAs. This discovery lays a baseline for further studies on the role of METTL8 in 













Result Part 4.2 
The mega-dalton protein complex of METTL8 binds to a subset of RNAs, 
specifically to the 5-terminal intron of LcRNA FTX. 
 
Fig 4.2.1 METTL8 complex binds to ncRNAs which is indispensable for its integrity 
A number of RNA splicing factors and RNA binding proteins were identified in the 
METTL8 nuclear complex suggest that the biological role of METTL8 is highly 
dependent on RNAs. With purified METTL8 complex in hand, utilizing small scale gel 
filtration chromatography, I designed an experiment proving that RNAs is an 
indispensible part of the METTL8 complex (Fig 4.2.1 A). Specifically, after 30 minute’s 
incubation at 37℃ together with either: MOCK, RNAase, DNAse and Proteinase, only 
RNAase and Proteinase treated METTL8 complex showed significant peak shift in 
molecular weight. The ability of RNAase and proteinase to dismantle the large molecular 
structure of METTL8 complex suggests that RNA and Protein are the building blocks 
which maintain a stabilized 3D structure of the METTL8 complex.  
 
Next, the RNAs were extracted from the gel filtration fractions (Fig 4.2.1 B) and both the 
METTL8 protein and the RNAs were visualized but either western blot or EtBr staining 
respectively (Fig 4.2.1 C). Additionally, using native PAGE gel, I also showed that the 
purified METTL8 complex runs at ~700 kDa and is sensitive to RNAase treatment (Fig 
4.2.1 D). Above data indicated that METTL8 and RNAs indeed co-fractions from the 
same large bio-molecule at a size of ~700 kDa, which leads us to the next question: what 
species of RNAs are METTL8 complex binding? 
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Fig 4.2.1 METTL8 complex binds to ncRNAs which is indispensable for its integrity 
A. Size exclusion chromatography of purified nuclear METTL8 complex indicated RNAs 
were indispensible for the complex integrity. The purified METTL8 complex was either 
mock treated with 37℃  water bath, or with 1U of RNAase I, 1 U of DNAase I or 1 U of 
Proteinase K. Then treated enzyme-complex mixture was loaded onto a Sepharose 12 gel 
filtration connected to FPLC system, proteins were eluted with one programmed method 
for all treatments. UV absorption at 280nm was recorded in real time and shown here. 
B. Nuclear METTL8 complex size exclusion chromatography plus RNA extraction from 
different fractions. Nuclear METTL8 complex was separated on size exclusion column 
and peak fractions were collected and subjected to TRIZOL RNA extraction, RNA 
concentration is measured using IMPLEN UV spectrometer. 
C. Westernblot and EtBr stained agarose gel of METTL8 complex components. Protein and 
RNA of the same batch of purified METTL8 complex were separately purified and 
visualized by either Westernblot or EtBr stained agarose gel respectively. 













Fig 4.2.2 METTL8 complex binds to FTX intron at 5’ end with prefer motif of UCCAC.  
 
In collaboration with Dr. He Chuan of University of Chicago, we were able to identify 
some of the binding RNAs of the METTL8 complex. Using Photoactivatable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) 
technology, FLAG tagged METTL8 binding proteins were pulled down from 293T cell 
line expressing stable FLAG tagged METTL8 protein, the binding RNAs were converted 
into cDNA and sent for deep sequence analysis. The majority (49%) of METTL8 binding 
RNA species were identified to be introns of tRNA or rRNA followed by 25% of inter- 
tRNA and rRNA and 17% of rRNA. Only a fraction (less than ~5%) actually binds to the 
3’ or 5’-UTR of mRNA indicating that METTL8 complex preferably binds to the introns 
of an unspliced RNA (Fig 4.2.2 A). Consensus binding motif analysis offered a clearer 
explanation for this binding pattern:  from the deep-seq data, the top METTL8 binding 
patterns are GC rich motif UCCAC and CACUC (Fig 4.2.2 B), suggested CpG island of a 
gene before the transcription start site could be the target site where METTL8 is enriched. 
It is reported that TREX binding proteins are enriched over R-loops hot spots near both 
ends of a gene body inducing genomic instability [47]. It is therefore reasonable to see 
METTL8’s binding RNAs to be mapped in the intron of a gene body.  
 
Next, based on the top listed METTL8 binding RNA candidates from PAR-CLIP, we 
choosed the top three RNAs with the most number of binding peaks, we did a validation 
PCR assay using RNAs purified from chromatographically purified METTL8 complex 
(Fig 4.2.1 C), out of the top three binding candidates (LINC RNA 473, FTX and XIST), 
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only FTX were shown to bind affinity purified complexes. Specifically, four pairs of 
FTX primers were designed targeting to the same peaks detect by Dr. HE Chuan, one pair 
of primer (FTX 177) showed strong binding to both of the individually purified METTL8 
complexes (complex 2 & 3), while the other three pairs (FTX 153, FTX 162 and FTX 
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Fig 4.2.2 METTL8 complex binds to FTX intron at 5’ end with preferred motif of UCCAC.  
A. PAR-CLIP analysis of RNA species binding to METTL8 complex. In 293T cells, 
METTL8 complex binding RNAs are cross-linked using photon, the complex is then 
pulled down using FLAG antibody, binding RNAs were converted into cDNAs and 
subjected to next generation deep sequencing. RNAs species are categorized based on 
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their sequence into 3’UTR, 5’UTR, COS, tRNA, rRNA, intron-t/r RNA and inter-t/r 
RNA. 
B. Consensus METTL8 complex binding motifs on RNA. Consensus binding motifs were 
determined based on sequencing data. 
C. Diagram of the X-inactivation locus on x-chromosome, FTX lies upstream of XIST and it 
is a METTL8 binding RNA detected by PAR-CLIP deep sequencing. 
D. rtPCR analysis of purified nuclear METTL8 complex binding RNAs. Oligo-nucleotide 
primers were designed around the locus of METTL8 binding sites detected in PAR-CLIP 
data, namely FTX153, FTX162, FTX176, and FTX177. Each primer were mixed with 
cDNA of reverse transcribed METTL8 complex binding RNAs extracted as shown in Fig 
4.2.1 C, they were amplified using a gradient annealing temperature to ensure efficiency, 















Conclusions for Result Part 4.2 
 
In this part of the study, we reported that METTL8 nuclear complex binds to a subset of 
RNAs at a molecular range of 200bp~1000bp. Moreover, based on a PAR-CLIP assay, 
the majority of METTL8 binding RNAs belonged to rRNA/tRNA family and one of the 
binding RNAs was identified to be FTX. FTX non-coding RNA was a known positive 
regulator for Xist in the male ES cells, here identified to be part of METTL8-TREX 
complex suggests it might also regulates gene expression of other gene targets such as 
rRNAs or tRNAs. This assumption is made because TREX complex was involved in R-
loops hotspots, and R-loop enrichment is not restricted to Pol II transcripts, very highly 
transcribed Pol I rDNA repeats also generates R Loops [48], additional studies done in 
Saccharomyces cerevisiae also showed the presence of R loops over Pol III transcribed 













Part 2 This epigenetic complex could relax chromatin and induce cell metastasis in a 
Sumoylation dependent manner 
 
Result Part 4.3 
New potential epigenetic factor METTL8 is Sumoylated at an evolutionary 
conserved site both in vitro and in vivo. 
 
Fig 4.3.1 METTL8 is Sumoylated in vivo at an evolutionary conserved site by the 
SAE1/SAE2/UBC9 sumoylase 
Human METTL8 protein has a theoretical molecular weight at 47 kDa; in human cervical 
cancer cell line HeLa, however, METTL8 protein is running at approximately 47 kDa in 
the cytosolic fraction but ~55kDa in the nuclear compartment (Fig 4.3.1 A). Moreover, to 
ensure the protein shift seem in the nucleus is not due to non-specificity of antibody, 
three different antibodies were used; same pattern was seem in the nucleus (Fig 4.3.1 B). 
This intriguing fact suggested that this protein is post-translational modified by possibly a 
rather large modifier with an approximate molecular weight at 10kDa. Using an online 
bioinfomatical motif scanner, the Eukaryotic Linear Motif (ELM) (Fig 4.3.1 C), together 
with ready-available amino acid sequence comparison data of METTL8 across organisms, 
I deduced there is an evolutionary conserved Sumoylation site at the N-terminus of 
METTL8, lysine 80 (K80) in human, it is the main reason for the molecular shift we see 




This Sumoylation modification site is identified to be at the METTL8 N-terminus SANT 
domain which is mainly responsible for protein-protein interaction which could be the 
docking site for enzyme-substrate recognition (Fig 4.3.1 D). By aligning amino acid 
sequences of five common organisms, we could see that the N-terminus of METTL8 
protein is much conserved at the site of Sumoylation, suggesting it is an important site for 
the function of METTL8 protein (Fig 4.3.1 E).  
 
Another worth-noticing fact, among its close related methyltransferase family of 
METTL2A/B and METTL6, METTL8 is the only protein owning a Sumoylation site (Fig. 
4.3.1 F&G). The other three members of the family, namely METTL2A/B and METTL6, 






























Fig 4.3.1 METTL8 is Sumoylated in vivo at an evolutionary conserved site by the 
SAE1/SAE2/UBC9 sumoylase. 
A. Westernblot analysis of METTL8 protein characteristics in fractioned or whole HeLa cell 
lysates. HeLa cells were either directly subject to lysis or the nuclear and cytoplasmic 
fractions were separated using a glass dounce humonegenizer. The protein were 
visualized using both endogenous antibody or exogenous HA antibody. 
B. Westernblot analysis of METTL8 protein characteristics in fractioned or whole HeLa cell 
lysates in parallel with three different antibodies. HeLa cells were either directly subject 
to lysis or the nuclear and cytoplasmic fractions were separated using a glass dounce 
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humonegenizer. The protein was visualized in parallel with molecular weight using 









































C. Eukaryotic Linear Motif search. Online conserve motif search, Sumoylation was detected 
as one of the many possible post-translational modifications of METTL8. 
D. Cartoon of METTL8 primary sequence and its functional domains. Main functional 
domains including N-terminal SANT domain, two segments of S-adenosyl methionine 
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binding domain and one nuclear receptor binding domain. The human Sumoylation site is 
at lysine 80 in the SANT domain. 
E. METTL8 primary sequence alignment across species at the site of Sumoylation, Human, 
mouse, cat, bat and fish METTL8 primary amino acid sequence was extracted from 
NCBI, N-terminal amino acids were aligned to indicate the site of Sumoylation is 






































F. Evolutionary tree of methyltransferases related to METTL8. METTL8 belongs to a 
























ID Position Peptide Score Cutoff Type 
METTL8 80 vlleeqvkyereask 42.977 16 Sumoylation 
METTL8 114-118 llrefpe ilpvd qkpeeka 69.451 59.29 SUMO interaction 
Mettl2A 216-220 cdfssta ielvq tnseydp 60.353 59.29 SUMO interaction 
Mettl2B 219-223 cdfssta ielvq tnseydp 60.353 59.29 SUMO interaction 
Mettl6 Nil Nil  Nil  Nil   Nil 
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Fig 4.3.2 In vitro assay showed METTL8 could specifically Sumoylation at lysine 80, 
and SUMO specific inhibitor Anacardic acid inhibits METTL8 Sumoylation in vitro. 
 
Next, to further validate the biochemical modification of the METTL8 protein, I 
artificially simulated METTL8 Sumoylation reaction in vitro. Based on a well-
established three-step enzyme reaction cascade (Fig 4.3.2 A); I constructed and purified 
all essential enzymes and substrates needed for this assay, including E1 (Sae1 & Sae2), 
E2 (UBC9), METTL8, METTL8K80R, SUMO1 and SUMO1gg. Also, known SUMO 
substrate P53 is incorporated as a positive control (Fig 4.3.2 B&C). In Fig 4.3.2 D, I 
showed that METTL8 is Sumoylated in vitro by SUMO1, SUMO2 but not SUMO3. 
Since SUMO2 and SUMO3 are highly similar to each other and are distinct from 
SUMO1, it is possible that METTL8 have unique functions when it is modified by 
different SUMO paralogs. However, due to the aim of our study, we did not look into the 
difference of function between these paralogs but rather focused on one type of 
Sumoylation. 
 
Besides having one of the major post-translational modifications of METTL8 defined. I 
further revealed the site of Sumoylation using both computational (Fig 4.3.1 C) and 
biochemical method (Fig 4.3.2 E). In the biochemical assay, point mutant METTL8-
K80R failed to be Sumoylated while it wild type counterpart is Sumoylated by SUMO1 
in vitro (Fig 4.3.2 E). This data lead me to the conclusion that METTL8 is specifically 





I also took advantage of available Sumoylation inhibitor (Fig 4.3.2 F) that specific target 
the E1-substrate, and incorporated it into in vitro Sumoylation assay. Result in Fig 4.3.2 
G showed that Anarcardic acid could inhibit in vitro SUMOlyation of METTL8 at a very 
low dose. Immunoprecipitation of nuclear-cytosol fractions of HeLa cells using SUMO-1 
antibody (Santa Cruz technology) have indicated METTL8 protein could be pulled-down 
by SUMO-1 antibody only in the nuclear fraction (Fig 4.3.2 H), but not in the cytosol 
fraction. Suggesting Sumoylation of METTL8 exclusively took place in the nuclear 
compartment of a cell, thus directing our attention to the unique qualities of this new 
epigenetic factor into the nucleus. In the next part of result, based on predictions stemmed 
from data presented above, I will reveal one of the most interesting nuclear functions of 
the METTL8 complex; this data would offer some directions on how METTL8 could 



































Fig 4.3.2 In vitro assay shows METTL8 can specifically Sumoylation at lysine 80, and SUMO 
specific inhibitor Anacardic acid inhibits METTL8 in vitro Sumoylation. 
A. Schematic diagram indicating the essential Sumoylation enzyme catalytic steps. The 
SUMO transferring cascade includes specific enzymes that are conserved across species, 
these enzymes include SUMO activating enzyme UIP, SAE1/SAE2 heterodimer E1, 
UBC9 transferring E2 and non-essential catalyst E3. 


































C. Sequencing result of human METTL8 lysine 80 point mutation. Human METTL8 un-
SUMO-able point mutation was generated by PCR method; mutated DNA was then 
ligated into bacterial expression vector and subjected to sequencing. 
D. In vitro Sumoylation of human METTL8 protein, bacterial purified METTL8 protein 
were incubated with E1, E2 and various analogs of SUMO proteins, band shift of 
Sumoylated METTL8 proteins were visualized with anti-hMETTL8 antibody. 
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E. In vitro Sumoylation of human METTL8 protein and human lysine 80 point mutation 
METTL8. Bacterial purified METTL8 protein and METTL8K80R protein were 
incubated with E1, E2 and various analogs of SUMO proteins, band shift of Sumoylated 
METTL8 proteins were visualized with anti-hMETTL8 antibody. Known SUMO 
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F. Molecular structure of Anacardic acid. Anacardic acids are phenolic lipids, a known 
inhibitor of E1-SUMO complex formation; it is the chemical compounds found in the 
shell of the cashew nut. 
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G. In vitro Sumoylation of human METTL8 protein and the inhibition of Sumoylation by 
SUMO inhibitor Anacardic acid. Bacterial purified METTL8 protein was incubated with 
E1, E2 and SUMO1, and increasing amount of Anacardic acid (1ug/ml, 2ug/ml 
respectively). Band shift of Sumoylated METTL8 proteins were visualized with anti-
hMETTL8 antibody. 
H. Immunoprecipitation of Sumoylated METTL8 using anti-SUMO1 antibody. Nuclear and 
cytoplasmic fractions of HeLa cells were incubated with anti-SUMO1 conjugated beads 
at 4℃ for 1 hour, proteins were visualized using westerblot using anti-FLAG antibody. 




















Fig 4.3.3 Protein 3D model suggests Sumoylation site is in proximity with S-
adenosylmethionine donor site on METTL8 which promotes enzyme-substrate complex 
formation 
 
Although the recombinant METTL8 protein is water-soluble and great efforts have been 
invested to solve the crystal structure of METTL8, our collaborator fails to deliver the 
structure, making it one of the most challenging problem for this project. To partially 
circumvent this problem and visualize the structure, I used an online 3D modeling 
programs available on http://zhanglab.ccmb.med.umich.edu/ to model METTL8 protein 
structure based on algorithm that compares existing structures with the unknown 
structure. After inputting METTL8 amino acid sequence to I-Tasser online server, the 
server generates a .PDB file that could be viewed by PDB viewer in 3D mode. Indicated 
by I-Tasser, the substrate binding domain where a methyl group is transferred to its 
substrate is situated at a pocket surrounded by alternative repeats of alpha-helix and beta-
sheets (Fig 4.3.3 B), more importantly, the lysine 80 site where Sumoylation took place is 
situated at a critical location where it functions as a “thumb” that covers the methyl donor 















Fig 4.3.3 Protein 3D model suggests Sumoylation site is in proximity with S-adenosylmethionine 
donor site on METTL8 which promotes enzyme-substrate complex formation 
A. 3D predicted structure of human METTL8 with highlight (dark red) of Sumoylation site. 
B. 3D predicted structure of human METTL8 with highlight (dark red) of Sumoylation site 











Conclusions for Result Part 4.3 
In this part of the study, based on the repeating occurrence of an extra band shifted 
~10kDa above the theorized molecular weight of METTL8, and online post-translational 
prediction algorithms, I pin-pointed and characterized an evolutionarily conserved 
Sumoylation site at the N-terminus of METTL8. This Sumoylation site is unique for 
METTL8 as none of its other family members also have this modification site, although 
some of its family members such as Mettl2A and Mettl2B also evolved to include a 
SUMO interaction motif (SIM), METTL8 remains to be the only member of the 
methyltransferase-like protein family that could be directly Sumoylated by SUMO E2 
UBC9.  
As I will explain in later chapters, the true Methyl substrate still remains elusive; 
nonetheless, METTL8 is still an important factor that could influences chromatin 
structure at a global scale (Fig 5.4.1). Given the example that Sumoylation of Mettl8 
interaction partner, TREX subunit Thoc1 only induces acid response genes when 
Sumoylated (Hugo Bretes, 2014). We could deduce that Sumoylation of METTL8 may 










Result Part 4.4 
METTL8 is a Sumoylation dependent euchromatin factor that relaxes chromatin 
and induces a subset of genes expression. 
 
Fig 4 .4.1 METTL8 complex conditions chromatin accessibility and activate selective 
groups of genes 
As I mentioned in Result Part 4.3, METTL8 is Sumoylated only in the nuclear 
compartment and since Sumoylation is a type of epigenetic modifications that is involved 
in various cellular processes, it is reasonable to speculate that such epigenetic factors 
have the ability to directly regulate chromatin dynamics and induces gene expression at a 
global level. Therefore a micrococcal nuclease sensitivity assay was used to test the 
change of chromatin accessibility to nucleic enzyme degradation during the induction of 
METTL8 protein expression.  
 
First, a Doxycycline inducible cell line is established, a gradient of METTL8 protein 
level can be achieved with different concentrations of Doxycycline (Fig 4.4.1 A). Next, 
using this cell line induced with different amount of METTL8 protein, I isolated the 
nuclei and treated it with micrococcal nuclease which cuts in between nucleosomes, 
meaning the more “relaxed” chromatin is more prone to nuclease digestion and vice versa, 
the more “compacted” chromatin are protected by nucleosomes from nuclease digestion. 
As shown in Fig 4.4.1 B, the level of digested chromatin by micrococcal nuclease in 
inverse correlation with the quantity of METTL8 protein induced by Doxycycline. 
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Conversely, the level of intact or undigested chromatin is linear correlation with the 
quantity of METTL8 protein induced by Doxycycline. As shown in Fig 4.4.1 C, after 
treating uninduced or induced METTL8 cell nuclei with micrococcal nuclease, the 
genomic DNA was extracted for each treatment and result indicated the cell nuclei with 
relative more METTL8 protein are more resistant to nuclease digestion than cells with 
relatively lower METTL8 protein level. Densitometry analysis of Fig 4.4.1 C indicated 
the difference of genomic DNA quantity is significantly different between induced cell 
verses uninduced cell (Fig 4.4.1 D). 
 
In conclusion, since the nucleus is organized in hierarchical orders such that the actively 
transcribing genes are situated in euchromatin where the chromatin is less compact and 
often labeled active epigenetic marks, and the silenced or less actively transcribed genes 
are confined in heterochromatin where the chromatin is compacted and marked with 
silencing epigenetic marks. The micrococcal nuclease assay data I present above suggests 
METTL8 is a heterochromatin inducing factor maintaining inhibition of genes, and 
Sumoylation of METTL8 protein in the nucleus could be another layer of epigenetic 
regulation that ensures an adequate amount of active METTL8 protein is present at 










































Fig 4.4.1 METTL8 complex conditions chromatin accessibility and activate selective groups of 
genes 
 
A. Western blot of Inducible METTL8 HeLa cells were treated with inducing agent, 
doxycycline. Inducible METTL8 expression cell line was selected and METTL8 protein 
is either induce by doxycycline at a gradient concentration or mock treated, protein 
content were analyzed with antibodies indicated in the figure. 
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B. Mnase sensitivity assay of inducible METTL8 Hela cells. After either doxycycline 
treated at a gradient concentration or mock treated, HeLa cell nuclei is then harvested and 
digested with equal unit of Mnase and genomic DNA of the Mnase digested cells is then 
purified and visualized on agarose gel.  
C. Mnase sensitivity assay of inducible METTL8 Hela cells. Gradient amount of Mnase was 
added into doxycycline induced or uninduced HeLa nuclei, genomic DNA of the Mnase 
digested cells is then purified and visualized on agarose gel.  





















Fig 4.4.2 METTL8 is an inducing factor for Metastasis and the ability of METTL8 
induced Metastasis is dependent on Sumoylation on its lysine 80. 
 
Encouraged by data indicating there is increased micrococcal nuclease sensitivity at the 
presence of METTL8 protein, I concluded that METTL8 is a critical factor with the 
ability to influence the genome accessibility to transcription machinery at global level. To 
validate the hypothesis that METTL8 could condition transcriptional landscape, in 
collaboration with Dr. Liu Xinyu and Dr. Hongyan, we took advantage of existing 
CRISPER-Cas9 RNA directed knockout technology, and generated METTL8 knock out 
cell line in 293T cell.  
 
A direct visual difference between wild type 293T cell and METTL8 gene knock out 
293T cell is it colony size, wild type cells migrate more rapidly/evenly that knock out cell 
which tend to form large colonies when cultured in petri-dish (data not shown). Naturally, 
the invasive ability of these cells was tested using BD invasion chamber. As shown in Fig 
5.4.2 A, the invasiveness of 293T cells is drastically compromised by CRISPER directed 
knocking out of METTL8 gene. Additionally, this loss of invasiveness could be rescued 
by transiently expressing wild type METTL8 gene but not METTL8 non-SUMOable 
K80R mutant (Fig 5.4.2 B). Suggesting Sumoylation is responsible for the activation of 

























Fig 4.4.2 METTL8 is an inducing factor for Metastasis and the ability of METTL8 induced 
Metastasis is dependent on Sumoylation on its lysine 80. 
A. Transwell analysis of the invasiveness of wild type and METTL8 knock out cell lines. 
Wild type and knock out 293T cells were seeded into the inner chamber of Transwell in 
growth medium without FBS, the inner chamber is then placed into the outer chamber 
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with 300ul of growth medium with 10% FBS. After 24hours of incubation, inner 
chamber cell colonies were removed with cotton swab and outer chamber cell colonies 
were stained with crystal violet for visualization under microscope. 
B. Transwell analysis of the invasiveness of the wild type, METTL8 knock out and knock 
out cell lines rescued with either wild type METTL8 expression vector or K80R 





















Conclusions for Result Part 4.4 
 
In this part of the study, by using conventional biochemical assays, and a 3rd generation 
inducible system, we showed that over-expression of METTL8 protein in vivo could 
induce global chromatin condensation. Functionally, over-expression of METTL8 
induces elevated level of cell migration and metastasis in tumor cell line while conversely, 
knocking-out of METTL8 reduce the level of cell migration drastically. This phenotype 
is consolidated by the fact that re-introducing METTL8 SUMO-defective mutant could 
not rescues lost of migration while wild type METTL8 could, in part, rescue the lost of 
















Result Part 4.5 
The naturally existed METTL8 complex is able to Methyl-label Histone H4 in vitro 
while artificially recombinant METTL8 protein fails to.  
 
Fig 4.5.1 METTL8 complex could transfer methyl group to Histone H4 in vitro. 
In an effort to identify the substrate for METTL8, we first tested Histone in nucleosome 
as possible substrates since METTL8 could induce nucleosome position change and 
binds to RNA splicing complex (Table 4.1.3) which is determined by nucleosome 
positioning [50].  As shown in Fig 4.5.1 A, purified METTL8 complex has the ability to 
methylate Histone H4 of core Histone (Fig 4.5.1 A, lane 4) but not polynuclesome (Fig 
4.5.1 A, lane 5), known Histone H4 methyltransferase Prmt5 was included as a positive 
control (Fig 4.5.1 A, lane 1). Additional to Prmt5, G9a is used for a second experiment; it 
is a Histone H3 methyltransferase, as shown in Fig 4.5.1 B (lane 1 verses lane 2,3,4,5) 
METTL8 immunoprecipitated complex clearly methyl-labels a different Histone 
comparing to G9a. The results appear to confirm that METTL8 complex is a Histone H4 
methyltransferase in vitro, however, above results are only sufficient enough to prove that 
METTL8 is active when directly isolated from cell. Because when METTL8 is isolated 
directly from the cell, it also brought together with all of its interaction partners and 
possibly some post-translational modifiers as well. Therefore, above mentioned results 
cannot prove that METTL8 is a Histone H4 methyltransferase per se. In order to assess 

































Fig 4.5.1 METTL8 complex could transfer methyl group to Histone H4 in vitro. 
A. Autoradiography showing in vitro methylation of Histone H4 by chromatographically 
purified METTL8 complex. Nuclear purified METTL8 complex was mixed with core 
Histones, together with 3H S-adenosyl methionine and incubated at 37℃ water bath for 1 
hour, after resolving the proteins on SDS-PAGE the vacuum-dried gel was subjected to 1 
week of exposure to X-ray film, the result indicated that nuclear METTL8 complex could 
methylate Histone H4 (lane 4), the same Histone as positive control PRMT5 (lane 1). 
B.  Autoradiography showing in vitro methylation of Histone H4 by immunoprecipitated 
METTL8 complex. Immunoprecipitated METTL8 complex is mixed with core Histones, 
together with 3H S-adenosyl methionine and incubated at 37℃ water bath for 1 hour, 
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after separation of proteins on SDS-PAGE; the vacuum-dried gel was subjected to 1 
week of exposure to a X-ray film. Result indicated that immunoprecipitated METTL8 
complex could methylate Histone H4 (lane 2-3), Histone H3 methylase G9a was included 



























Fig 4.5.2 METTL8 recombinant protein does not have the ability to transfer Methyl 
group to any Histones. 
 
In order to consolidate the nature of METTL8 as a potential methyl transferring 
epigenetic enzyme, I forth purified the human recombinant wild type and S-Adenosyl 
methionine (SAM) binding domain deleted METTL8 protein from bacterial expression 
system using affinity chromatography (Fig 4.5.2 A), polynucleosomes and core Histones 
are either purified from HeLa cell nuclei (Fig 4.5.2 A) or directly purchased, respectively. 
Additional to previously mentioned Prmt5, to ensure a valid reaction is performed, a 
known recombinant methyltransferase enzyme that does not need any co-factors to be 
active (DOTL1, Fig 4.5.2 B, lane 7) is also purified using the same method (affinity 
chromatography) for positive control. As shown in Fig 4.5.2 B, neither WT METTL8 nor 
WT METTL8 together with one its binding co-factor (WDR45L) could methyl-label any 
of the core Histones (Fig 4.5.2 B, lane 2, 4). This suggests that METTL8 pure protein is 
not methyl-transferring competitive, even when mixed together with one of its known co-
binding factor WDR45L, METTL8 recombinant protein remains inactive. One possible 
explanation for METTL8 being active when isolated from cell and inactive when it is 
purified as recombinant protein is previously characterized posttranslational modification 
(Sumoylation) (Result part 4.3). Because Sumoylation could induce an enzyme to change 
its substrate binding pocket conformation [51, 52], thus allowing the SUMO modified 
METTL8 to bind to Histone and catalyze the transferring of methyl group. Moreover, a 
second reason for the inactivity of recombinant METTL8 could also due to necessary 
potential co-factor(s). With METTL8’s ~30 interaction partners identified by Mass-
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spectrometry (Result part 4.1), we cannot eliminate the possibility that besides WDR45L, 
other co-factor(s) could also influence METTL8’s activity. 
 
 




















Fig 4.5.2 METTL8 recombinant protein does not have the ability to transfer Methyl group to any 
of the Histones. 
 
A. Coomassie staining of purified proteins used for in vitro methylation assays. To ensure 
the purity of protein used in in vitro methylation assay, all proteins were 
chromatographically purified and examined on SDS-PAGE gel using Coomassie staining. 
C. Autoradiography showing recombinant METTL8 could not methylate Histone H4 using 
in vitro method. Recombinant human METTL8 was mixed with core Histones, together 
with 3H S-adenosyl methionine and incubated at 37℃ water bath for 1hour, after resolving 
101 
 
the proteins on SDS-PAGE and 1 week of exposure to a X-ray film, the result indicated 
that recombinant human METTL8 could not methylate Histone H4 (lane 2-3), while 
recombinate Histone H3 methylase DOTL1 could methylate core Histones even at a 
lower substrate concentration (lane 7). 
 
Conclusions for Result Part 4.5 
 
In this part of the study, based on prior results showing that METTL8 has an chromatin 
condensing ability in vivo (Fig 4.4.1), and METTL8 binds to protein machineries that are 
actively involved in RNA metabolism at the sites of active transcribing genes (Table 
4.3.1), I hypothesize that METTL8 activates the chromosome through its main structural 
component, the Histone. Utilizing in vitro 3H isotope labeling method, I tested the 
possibility of METTL8 labeling core nucleosome and polynucleome, and I concluded 
that METTL8 complex has the ability to label Histone H4 while METTL8 protein alone 
do not have any methyltransferase activity. The reason for this most likely due to 
necessary postranslation modification needed on METTL8, examples of METTL8 
postranslational modification can be found both in my work (Sumoylation) and from Dr. 













Chapter 5: Discussion 
 
 
5.1 Functional link between methyltransferase complex and transcription landscape 
 
This study investigated on how sumoylation could activate a new Histone H4 
methyltransferase (METTL8), and how it could transcriptional activates a group of gene 
by remodeling chromatin landscape in the nucleus. It was found that the SANT domain 
containing methyltransferese METTL8 potentially remains latent in the cytosol until 
activated by sumoylase UBC9 modifying a lysine residue at the SANT domain. Since 
Sumoylation is known to be a major signal for protein-protein interaction, the 
sumoylation opens the SANT domain structure functioning as a recruitment site for co-
factors binding, this is essential for both activation of the methyltransferase enzyme 
activity but also initiating chromatin-remodeling complex formation. At the same time, 
Mnase sensitivity data indicates this novel chromatin-remodeling complex activates gene 
transcription by decreasing chromatin compaction, which exposes DNA for transcription 
machinery binding. The major differences between METTL8 methylatransferase 
complex and classical methylatransferase complexes like the PRC1/PRC2 complex [53] 
is that it not only requires a complex to form in order to be active, but it is also responsive 
to environmental stresses that induce sumoylation. Our data demonstrated how 
environmental cues could triggers epigenetic changes in the cell at a molecular level. 
 
Furthermore, the METTL8 methyltransferase complex is purified from the cell nucleus 
and compartment. Mass spectrometry analysis indicated the interacting subunits of the 
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METTL8 complex are mainly involved in RNA metabolism and DNA damage response 
pathway. The main interacting partners responsible for RNA metabolism are the 
spliceosome subunits SFPQ-NONO-Matr3 and the RNA transcription and export subunit 
TREX. The main interacting partners for DNA damage response pathway are the 
DNAPK complex and NFAT complex which implies METTL8’s unique biological 
functions [6]. We focused on the function of nuclear METTL8 complex because 
epigenetic regulation starts in the nucleus at the transcription sites while successful 
maturation of freshly transcribed pre-mRNAs also has profound impact on a cell’s 
identity. These freshly transcribed mRNAs are spliced, modified and transported to 
nuclear pore complex (NPC) by an elaborate networks of protein complexes, and here in 
our study, THO subcomplex of the TREX complex are shown to be the potential linking 
point on which METTL8 took part in. 
 
Genetic models of THO mutation are extensively studied in yeast, mice and human cells, 
amazing similarities are present in between METTL8 knockout and THOC1 knockout 
mice: In yeast, THO mutant result in transcription-associated hyper-recombination and it 
is directly associated with R-loop formation [54]. In mice, THO KO is embryonic lethal 
but hypomorphic allele of THOC1 would lead to male infertility and abnormal testicular 
tubules [55]. In human, KD of THO would induce DNA damage response and therefore 
genome instability [56], which is the same phenotype when you knock out METTL8. 
These studies are coherent with the notion that METTL8 function is involved in many 





5.2 Potential mechanisms of Sumoylation mediated chromatin remodeling 
 
Mechanistically, in vitro Sumoylation assay showed that WT METTL8 could be 
specifically Sumoylated upon incubation with SUMO1 while Mutant METTL8 fails to. 
This result is coherent with previous prediction that nuclear METTL8 is Sumoylated in 
vivo in order to be active; which provided a basis for the discovery of METTL8 substrate. 
Our in vitro and in vivo data has suggested: upon Sumoylation, METTL8 is potentially 
enzymatically activated and transfers a methyl group to the Histone H tail. Because it was 
known that a Histone mark can be either activating or silencing [3], and METTL8 are 
mainly enriched at activated genomic sites, we should examined relevant Histone 
residues that demarcate euchromatin in future studies.  
 
Based on the METTL8 complex composition, the molecular function of the nuclear 
METTL8 complex is elucidated: METTL8 binds to THOC1 subunit of TREX complex 
which is a linking step from mRNA splicing to RNA export. METTL8 is an essential part 
of the RNA transcription-transport cascade ensuring actively transcribed genes are 
efficiently released from the DNA template to prevent the formation of R-loops which is 
an inducing factor for genome instability. SUMO-activated METTL8 bind to THOC1 and 
other components of the TREX complex mainly because THOC1 is also regulated by 
Sumoylation as proven by other group [22], Sumoylated proteins tend to recruit other 
Sumoylated proteins via their SUMO Interacting Motif (SIM) and forms macro-
molecular complex mediating gene expression, and among its related family members 
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(Fig 4.3.1 F), SIM domain was found exclusively on METTL8 only (Fig 4.3.1 G). 
Activated METTL8-TREX therefore binds to its adjacent nucleosome and transfers a 
Methyl group to the Histone H4. This epigenetic mark indicates gene activation and 
allows chromatin remodeling macro-complexes to recognize and loosen compact 
chromatin.  
 
5.3 R-loop and genome stability and gene regulation 
 
Our mass spectrometry data suggested a link between METTL8 and genome instability 
inducing agent: DNA: RNA hybrid, this is because METTL8-THOC1 is the main 
regulator of DNA: RNA hybrids dynamic at actively transcribing genomic sites. 
METTL8 is likely to facilitate efficient nascent RNA release at the sites of active gene 
regions where Pol IIs is transcribing RNAs, or transcription hotspots, this hypothesis is 
support by mass spectrometry data indicating some general transcription factors like 
GTFII which also co-purify from METTL8 complex. 
 
Our work on METTL8, which is a potential epigenetic factor, shed light on new 
pathways in R-loop regulation of epigenetic events. It have been proposed by Ginno et al. 
that displaced single stranded DNAs could act as a source for signals that recruits 
epigenetic factors to modify Histones for protective marks and DNA demethylase 
complexes. METTL8 could escalate its epigenetic power through binding to R-loops at 
transcription hot spots and recruit other epigenetic machineries through its SAM domain, 
and recent computational studies has also revealed there are indeed DNA hotspots in the 
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genome where RNA loop forms at genes that are actively involved in diseases 
( Wongsurawat et al. 2012).  
 




METTL8 as an R-loops stabilizing factor 
Previous studies have shown R-loops to be a transcription byproducts that presented as a 
threat to genome stability [57], and many protein factors including Topoisomerase I, 
BRCA1  and Senataxin are found to be essential factors that removes R-loops either 
through their ability to unwind DNA/RNA hybrid or to remove hybrid RNA by 
endonuclease cleavage [47, 58, 59]. However, positive regulators of R-loops remain 
unknown. Since R-loops are abundant natural occurring structure in the nucleus, they 
have important regulatory functions as well. GC rich pause sites are the common locus 
where R-loops are necessary for Pol II to pause transcription downstream of Poly (A) 
sites [47, 60].  
Here, through proteomic identifications of METTL8 binding partners, we identified the 
first epigenetic factor that stabilizes R-loops especially in the nucleolus (Fig. 5A&B). 
Importantly, deletion of METTL8 from the genome induces lost of R-loops structures 
downstream of Poly (A) (Fig. 5C), which result in transcriptional read through, and 
consequently, elevated mRNA expression level in some genes (Fig. 6C). These findings 
provided an epigenetic mechanism in which transcription is not only modulated at the 
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start site, such as promoter CpG methylation [61], but also exquisitely regulated at the 
terminating end.  
 
METTL8-THOC1 complex and its implication in RNA biology 
In accordance to its regulatory rule in RNA metabolism, the METTL8 complex was also 
identified to be an RNA-binding protein complex (Fig. 2A-D). Although METTL8 itself 
does not contain a RNA recognition motif (RRM), RNA is indispensible for the integrity 
of nuclear METTL8 complex (Fig. 2E), suggesting either RNA induces the formation of 
METTL8 ribonucleoprotein complex (METTL8 RNPs) or METTL8 and its co-binding 
proteins are indispensible for RNA metabolism. As our large scale complex purification 
and mass-spectrometry data (Table S1) have demonstrated, majority of the METTL8 
binding proteins are either RNA binding proteins (DHX9, RBM27, USP39) or are well-
defined protein complexes that is involved RNA metabolism (THO RNA transport 
complex, SFPQ-NONO-MATR3 splicing complex, cleavage factor Im (CFIm) complex).  
 
Sumoylation and its control to transcription 
Through the regulation of R-loops at 3’ transcription pause-site and implications in RNA 
biology, we identify METTL8 in the realm of RNAs. More interestingly, a superior layer 
of regulatory mechanism was also discovered to impose regulatory rules on METTL8 
(Fig. 3). Sumoylation at an evolutionary well-conserved site (K80 in human) was found 
to be critical for METTL8 nucleolus localization (Fig. 3G). Which implicates 
Sumoylated METTL8 are recruited to nucleolus where it function as an R-loops 
stabilizing factor. Supported by another group showing R-loop related factor, DNA 
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topoisomerase I (TOP1) is also regulated by sumoylation [62], we predict sumoylation 
serves as a common mechanism which Sumoylated proteins are recruited to form 
dynamic multi-subunit complex through Sumoylation Interacting Motifs (SIMs) [63, 64]. 
 
6.2 Future works 
Considering that the study of environmentally activated epigenetic pathway is still at its 
infant stage, the following directions should not be overlooked in future research. 
 
1. Beside its nuclear methyltransferase activity, a large amount of METTL8 was also 
found to be located in the cytosol, their function still remain elusive. Since our 
study suggested that cytosolic METTL8 lacks enzyme activity, their function and 
the signal pathway activates METTL8 should be an interesting question to follow. 
 
2. Although sumoylation was identified to be the signal that activates METTL8 
epigenetic function, a few other well-conserved potential modification sites were 
also found in METTL8. It is reasonable to foresee that other types of 
modifications such as acetylation and glycosylation may also be factors involved 
in environmental epigenetic response.  
 
3. With all of its interacting protein purified in the nucleus, how each component 
contributes to METTL8 overall activity is still a question to be answer. More 
mechanistic studies should be pursued to figure out not only how protein complex 
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